Evidence map›Paper›PMID 35420997›Full record

ArticleJCI insight2022

Sine oculis homeobox homolog 1 plays a critical role in pulmonary fibrosis.

Cory Wilson, Tinne Cj Mertens, Pooja Shivshankar, Weizen Bi, Scott D Collum, Nancy Wareing, Junsuk Ko, Tingting Weng, Ram P Naikawadi, Paul J Wolters and 10 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Murine models of pulmonary fibrosis: mechanisms, limitations and translational insights.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  2. Journal of thoracic disease · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 9 institutions in 2 countries.

Cory WilsonDepartment of Biochemistry and Molecular Biology, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth Houston), Houston, Texas, USA.
Tinne Cj MertensDepartment of Biochemistry and Molecular Biology, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth Houston), Houston, Texas, USA.
Pooja ShivshankarDepartment of Biochemistry and Molecular Biology, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth Houston), Houston, Texas, USA.
Weizen BiDepartment of Biochemistry and Molecular Biology, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth Houston), Houston, Texas, USA.
Scott D CollumDepartment of Biochemistry and Molecular Biology, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth Houston), Houston, Texas, USA.
Nancy WareingDepartment of Biochemistry and Molecular Biology, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth Houston), Houston, Texas, USA.
Junsuk KoDepartment of Biochemistry and Molecular Biology, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth Houston), Houston, Texas, USA.
Tingting WengDepartment of Biochemistry and Molecular Biology, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth Houston), Houston, Texas, USA.
Ram P NaikawadiPulmonary, Critical Care, Allergy and Sleep Medicine, UCSF, San Francisco, California, USA.
Paul J WoltersPulmonary, Critical Care, Allergy and Sleep Medicine, UCSF, San Francisco, California, USA.
Pascal MaireUniversité de Paris Cité, Institut Cochin, INSERM, CNRS, Paris, France.
Soma Sk JyothulaDivisions of Critical Care, Pulmonary and Sleep Medicine, Department of Internal Medicine, McGovern Medical School, UTHealth, Houston, Texas, USA.
Rajarajan A ThandavarayanMethodist J.C. Walter Jr. Transplant Center, Houston Methodist Hospital, Houston, Texas, USA.
Dewei RenMethodist J.C. Walter Jr. Transplant Center, Houston Methodist Hospital, Houston, Texas, USA.
Nathan D ElrodDepartment of Biochemistry and Molecular Biology, University of Texas Medical Branch at Galveston, Galveston, Texas, USA.
Eric J WagnerDepartment of Biochemistry and Biophysics, Center for RNA Biology, Wilmot Cancer Institute, University of Rochester School of Medicine and Dentistry, KMRB G.9629, Rochester, New York, USA.
Howard J HuangMethodist J.C. Walter Jr. Transplant Center, Houston Methodist Hospital, Houston, Texas, USA.
Burton F DickeyDepartment of Pulmonary Medicine, Division of Internal Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
Heide L FordDepartment of Pharmacology, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA.
Harry Karmouty-QuintanaDepartment of Biochemistry and Molecular Biology, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth Houston), Houston, Texas, USA.
The University of Texas Health Science Center at Houston · USMethodist Hospital · USPulmonary and Allergy Associates · USThe University of Texas Health Science Center · USCentre National de la Recherche Scientifique · FRThe University of Texas MD Anderson Cancer Center · USThe University of Texas Medical Branch at Galveston · USUniversity of Colorado Anschutz Medical Campus · USUniversity of Rochester · US

Funding

Lung Remodeling Mediated by Telomere Dysfunction in Alveolar Type II CellsR01HL139897 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Paul j WOLTERS · 2018 to 2026
$5.5M
Controlling the core airway mucin secretion machinery to prevent pathophysiologyR01HL129795 · NHLBI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DICKEY, BURTON F · 2015 to 2023
$3.8M
Sineoculis Homeobox Homolog 1 (Six1) in Pulmonary FibrosisR01HL157100 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI KARMOUTY-QUINTANA, HARRY · 2021 to 2025
$2.8M
3'UTR Shortening In Pulmonary Vascular DiseaseR01HL138510 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI KARMOUTY-QUINTANA, HARRY · 2017 to 2021
$2.3M
Pulmonary Fibrosis: Novel Role for Developmental Gene Six1 in Alveolar Type II CellsF30HL147508 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI WILSON, CORY · 2019 to 2020
$58k
NHLBI NIH HHS F30 HL147508NHLBI NIH HHS R01 HL129795NHLBI NIH HHS R01 HL138510NHLBI NIH HHS R01 HL139897NHLBI NIH HHS R01 HL157100
6 · The paper itself

Abstract

Idiopathic pulmonary fibrosis (IPF) is a fatal disease with limited treatment options. The role of the developmental transcription factor Sine oculis homeobox homolog 1 (SIX1) in the pathophysiology of lung fibrosis is not known. IPF lung tissue samples and IPF-derived alveolar type II cells (AT2) showed a significant increase in SIX1 mRNA and protein levels, and the SIX1 transcriptional coactivators EYA1 and EYA2 were elevated. Six1 was also upregulated in bleomycin-treated (BLM-treated) mice and in a model of spontaneous lung fibrosis driven by deletion of Telomeric Repeat Binding Factor 1 (Trf1) in AT2 cells. Conditional deletion of Six1 in AT2 cells prevented or halted BLM-induced lung fibrosis, as measured by a significant reduction in histological burden of fibrosis, reduced fibrotic mediator expression, and improved lung function. These effects were associated with increased macrophage migration inhibitory factor (MIF) in lung epithelial cells in vivo following SIX1 overexpression in BLM-induced fibrosis. A MIF promoter-driven luciferase assay demonstrated direct binding of Six1 to the 5'-TCAGG-3' consensus sequence of the MIF promoter, identifying a likely mechanism of SIX1-driven MIF expression in the pathogenesis of lung fibrosis and providing a potentially novel pathway for targeting in IPF therapy.

Indexed as

Homeodomain ProteinsIdiopathic Pulmonary FibrosisAnimalsFibrosisGenes, HomeoboxMiceTranscription FactorsHomeodomain ProteinsTranscription FactorsFibrosisPulmonology

Identifiers

PMID35420997
PMCPMC9220956
OpenAlexW4223962291

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.